| Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) M Dougados, M Soubrier, A Antunez, P Balint, A Balsa, MH Buch, ... Annals of the rheumatic diseases 73 (1), 62-68, 2014 | 1084 | 2014 |
| Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention HE Vonkeman, MAFJ van de Laar Seminars in arthritis and rheumatism 39 (4), 294-312, 2010 | 443 | 2010 |
| Non-steroidal anti-inflammatory drugs: an overview of cardiovascular risks IL Meek, MAFJ Van de Laar, HE Vonkeman Pharmaceuticals 3 (7), 2146-2162, 2010 | 306 | 2010 |
| Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis CS Crowson, S Rollefstad, E Ikdahl, GD Kitas, PLCM Van Riel, SE Gabriel, ... Annals of the rheumatic diseases 77 (1), 48-54, 2018 | 296 | 2018 |
| Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients EK Richfield, KA Maguire‐Zeiss, HE Vonkeman, P Voorn Annals of neurology 38 (6), 852-861, 1995 | 185 | 1995 |
| Neuropathic-like pain features and cross-sectional associations in rheumatoid arthritis SMW Koop, PM ten Klooster, HE Vonkeman, LMM Steunebrink, ... Arthritis research & therapy 17, 1-8, 2015 | 174 | 2015 |
| How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis L Siemons, PM Ten Klooster, HE Vonkeman, PLCM van Riel, CAW Glas, ... BMC musculoskeletal disorders 15, 1-7, 2014 | 135 | 2014 |
| Impact of patient-accessible electronic medical records in rheumatology: use, satisfaction and effects on empowerment among patients R van Der Vaart, CHC Drossaert, E Taal, KW Drossaers-Bakker, ... BMC Musculoskeletal Disorders 15, 1-9, 2014 | 126 | 2014 |
| Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial CA Janssen, MAH Oude Voshaar, HE Vonkeman, TLTA Jansen, ... Rheumatology 58 (8), 1344-1352, 2019 | 115 | 2019 |
| Eradication of Helicobacter pylori Does Not Reduce the Incidence of Gastroduodenal Ulcers in Patients on Long‐term NSAID Treatment: Double‐Blind … HTJI De Leest, KSS Steen, WF Lems, JWJ Bijlsma, MAFJ Van De Laar, ... Helicobacter 12 (5), 477-485, 2007 | 113 | 2007 |
| Stopping tumor necrosis factor inhibitor treatment in patients with established rheumatoid arthritis in remission or with stable low disease activity: a pragmatic multicenter … M Ghiti Moghadam, HE Vonkeman, PM Ten Klooster, J Tekstra, ... Arthritis & rheumatology 68 (8), 1810-1817, 2016 | 107 | 2016 |
| Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study IL Meek, HE Vonkeman, J Kasemier, KLL Movig, M Van De Laar European journal of clinical pharmacology 69, 365-371, 2013 | 97 | 2013 |
| Performance of the Dutch SF-36 version 2 as a measure of health-related quality of life in patients with rheumatoid arthritis PM ten Klooster, HE Vonkeman, E Taal, L Siemons, L Hendriks, ... Health and quality of life outcomes 11, 1-9, 2013 | 94 | 2013 |
| Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial SHM Manders, W Kievit, E Adang, HL Brus, HJB Moens, A Hartkamp, ... Arthritis research & therapy 17, 1-12, 2015 | 85 | 2015 |
| Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands WH Bos, A van Tubergen, HE Vonkeman Rheumatology international 41 (3), 565-573, 2021 | 84 | 2021 |
| Direct medical costs of serious gastrointestinal ulcers among users of NSAIDs HE Vonkeman, RM Klok, MJ Postma, JRBJ Brouwers, MAFJ Van De Laar Drugs & aging 24, 681-690, 2007 | 83 | 2007 |
| Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice GA Versteeg, LMM Steunebrink, HE Vonkeman, PM Ten Klooster, ... Clinical rheumatology 37, 1189-1197, 2018 | 70 | 2018 |
| Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey I Nota, CHC Drossaert, E Taal, HE Vonkeman, MAFJ van de Laar BMC musculoskeletal disorders 15, 1-10, 2014 | 66 | 2014 |
| Disseminated primary varicella infection during infliximab treatment H Vonkeman, C Napel, H Rasker, M van de Laar Journal of rheumatology 31 (12), 2517-2518, 2004 | 66 | 2004 |
| International consortium for health outcome measurement set of outcomes that matter to people living with inflammatory arthritis: consensus from an international working group MAH Oude Voshaar, Z Das Gupta, JWJ Bijlsma, A Boonen, J Chau, ... Arthritis care & research 71 (12), 1556-1565, 2019 | 65 | 2019 |
